NCT07048821

Brief Summary

Hashimoto's thyroiditis (HT) is an autoimmune disease affecting the thyroid gland and is one of the most common causes of hypothyroidism. Eating habits may affect the risk of several inflammatory and immune diseases, such as HT. The current knowledge of the diet in HT is insufficient. The Mediterranean diet (MD) is an anti-inflammatory diet characterized by frequent consumption of olive oil, unrefined cereals, fresh or dried fruit and vegetables, moderate amounts of fish, dairy, and meat, and many condiments and spices. It is rich in nutrients and bioactives, which have the potential to offer anti-inflammatory aspects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 5, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

June 17, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
Last Updated

July 2, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

June 17, 2025

Last Update Submit

June 24, 2025

Conditions

Keywords

Anti-TPOAnti-TGHashimoto ThyroiditisMediterranean DietThyPRO questionnaire

Outcome Measures

Primary Outcomes (4)

  • Changes in the serum level of anti-TPO and Anti-TG antibodies

    IU/ml

    after 3 months of dietary modification

  • Changes in the serum level of TSH

    uIU/ml

    after 3 months of dietary modification

  • Changes in the serum level of free T3

    pg/ml

    after 3 months of dietary modification

  • Changes in the serum level of free T4

    ng/dl

    after 3 months of dietary modification

Secondary Outcomes (3)

  • changes in BMI

    after 3 months of intervention

  • changes in serum level of total cholesterol, triglyceride, low-density lipoprotein, high-density lipoprotein

    after 3 months of intervention

  • Symptoms of hypothyroidism

    after 3 months of intervention

Study Arms (1)

patients with hashimoto thyroiditis

EXPERIMENTAL

The investigators advised patients to follow a modified Mediterranean diet plan with a reduction in goitrogenic foods for 12 weeks.

Dietary Supplement: Dietary modification

Interventions

Dietary modificationDIETARY_SUPPLEMENT

3-month dietary plan

Also known as: Mediterranean diet
patients with hashimoto thyroiditis

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with symptoms of hypothyroidism (hypothyroid/euthyroid)
  • Positive anti-thyroid antibodies (anti-TPO/anti-TG).

You may not qualify if:

  • Pregnant or lactating females
  • Age below 20 years and above 50 years
  • presence of any other medical disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University hospital

Cairo, 002, Egypt

Location

Related Publications (5)

  • Groenewegen KL, Mooij CF, van Trotsenburg ASP. Persisting symptoms in patients with Hashimoto's disease despite normal thyroid hormone levels: Does thyroid autoimmunity play a role? A systematic review. J Transl Autoimmun. 2021 Apr 15;4:100101. doi: 10.1016/j.jtauto.2021.100101. eCollection 2021.

  • Watt T, Hegedus L, Bjorner JB, Groenvold M, Bonnema SJ, Rasmussen AK, Feldt-Rasmussen U. Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism? Eur Thyroid J. 2012 Oct;1(3):186-92. doi: 10.1159/000342623. Epub 2012 Sep 29.

  • Watt T, Hegedus L, Groenvold M, Bjorner JB, Rasmussen AK, Bonnema SJ, Feldt-Rasmussen U. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol. 2010 Jan;162(1):161-7. doi: 10.1530/EJE-09-0521. Epub 2009 Oct 1.

  • Danailova Y, Velikova T, Nikolaev G, Mitova Z, Shinkov A, Gagov H, Konakchieva R. Nutritional Management of Thyroiditis of Hashimoto. Int J Mol Sci. 2022 May 5;23(9):5144. doi: 10.3390/ijms23095144.

  • Bellastella G, Scappaticcio L, Caiazzo F, Tomasuolo M, Carotenuto R, Caputo M, Arena S, Caruso P, Maiorino MI, Esposito K. Mediterranean Diet and Thyroid: An Interesting Alliance. Nutrients. 2022 Oct 4;14(19):4130. doi: 10.3390/nu14194130.

MeSH Terms

Conditions

Hashimoto Disease

Interventions

Diet TherapyDiet, Mediterranean

Condition Hierarchy (Ancestors)

Thyroiditis, AutoimmuneThyroiditisThyroid DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeuticsDiet, Plant-BasedDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Manal Abushady, MD

    faculty of medicine, Ain Shams University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer of Endocrinology and Internal Medicine Faculty of Medicine, Ain Shams University Cairo, Egypt

Study Record Dates

First Submitted

June 17, 2025

First Posted

July 2, 2025

Study Start

May 5, 2023

Primary Completion

September 15, 2023

Study Completion

September 15, 2023

Last Updated

July 2, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations